Cancer Drug "Oversized" Single-Dose Vials Waste Money, Need Rethinking – Article
This article was originally published in The Pink Sheet Daily
Amgen, Takeda and Merck push back against article’s conclusions on the waste generated by current vials for infused drugs.
You may also be interested in...
The upcoming implementation of a new ‘refund’ program for unused drugs included in single-use vials is a remarkable story of a policy idea moving from academic research into the real world. But the actual impact sure has shrunk along the way.
Regulation from CMS may drive manufacturers to repackage Medicare Part B drugs sold in single-use containers to avoid waste that would be subject to new rebate.
Manufacturers who sell single-use vials for products covered by Part B have about 16 months to consider pricing or packaging changes that may minimize exposure to a new refund for ‘wasted’ drug.